IKA Keratoconus Symposium provides access to expert opinions, latest research

Publication
Article
Optometry Times JournalMay digital edition 2023
Volume 15
Issue 05

The goal of the inaugural International Keratoconus Academy (IKA) Keratoconus Symposium in Scottsdale, Arizona, was to help preserve vision.

IKA Keratoconus Symposium Consensus Statement:

Because of the increased prevalence rates of keractoconus, in an optimal setting and in addition to their annual comprehensive eye examination, children should have at least 1 corneal tomography scan (corneal topography if corneal tomography is not available) by the age of 10 to 12 years old to rule out the presence of early ectatic corneal diseases. This is most important if there is a family history of keratoconus, decreased best corrected visual acuity, high refractive error, or any known risk factors for keratoconus.

Image Credit: © Zarina Lukash - adobe.stock.com

(Adobe Stock / Zarina Lukash)

The goal of the inaugural International Keratoconus Academy (IKA) Keratoconus Symposium in Scottsdale, Arizona, was to help preserve vision.

“This meeting changed the way I practice.” “The speakers were amazing.” “Best CE [meeting] I’ve been to in a very long time.”
“I cannot believe this was a first-time conference.” These are just a few of the comments I and the other chairs heard around the conference floor.

To say that we were blown away by the responses from the attendees, sponsors, and conference support staff is a huge understatement. Some of the most important and relevant discussions revolved around the significantly higher prevalence of keratoconus than previously understood and the need to identify and treat in the pediatric population as early as possible.

The mission of the inaugural IKA Keratoconus Symposium was to provide the highest quality education possible for the continuum of care for individuals with keratoconus. We picked the most relevant topics and then searched for the best possible faculty to address those topics. Inclusion of all eye care providers was paramount because all courses included both expert optometrists and ophthalmologists. We went out of our way to find eye doctors with keratoconus to discuss their personal experience. We wanted to address all aspects of the disease: diagnosis, assessment, genetics, proper billing and coding, medical contact lenses, and all treatments including corneal crosslinking, combined cataract surgery, and corneal transplantation.

We addressed special populations with keratoconus and their specific but less understood and highly specialized needs. We gave special attention to the population with Down syndrome as well as those in the US military (there are considerations for those who want to enlist or those who receive a diagnosis after they put on the uniform). Including industry partners such as the National Keratoconus Foundation to aid in education was also vital.

The symposium was also a gathering of significant knowledge, and we wanted to harness that knowledge into enduring documents that could help guide the primary eye care physician to provide the highest quality care for patients with keratoconus or refer them at the most appropriate time to specialized care. As a result, content was collected during designated sessions to build a group algorithm of care that will ultimately be available to eye care providers worldwide.

At the end of the day, the reason why we are here is to care for our patients. We know they are sometimes scared or worried about their most important sense, their vision. They have questions, and they want answers. So we invited them to participate in an online session with some of our expert ophthalmologists and optometrists. It was incredible to bring patients into our conference and answer their questions.

Overall, the IKA Keratoconus Symposium was a tremendous success. But it wasn’t enough; IKA needs to share this information with as many eye care providers as possible. Look out for our quarterly free webinars, presentations at upcoming eye conferences, journal articles, and most importantly, the 2nd Annual IKA Keratoconus Symposium from May 18 to 19, 2024, in Bethesda, Maryland.

Recent Videos
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.